Search Results - "Yang, Joy"

Refine Results
  1. 1
  2. 2

    Resolving the structure of phage–bacteria interactions in the context of natural diversity by Kauffman, Kathryn M., Chang, William K., Brown, Julia M., Hussain, Fatima A., Yang, Joy, Polz, Martin F., Kelly, Libusha

    Published in Nature communications (18-01-2022)
    “…Microbial communities are shaped by viral predators. Yet, resolving which viruses (phages) and bacteria are interacting is a major challenge in the context of…”
    Get full text
    Journal Article
  3. 3

    lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs by Yang, Liuqing, Lin, Chunru, Jin, Chunyu, Yang, Joy C., Tanasa, Bogdan, Li, Wenbo, Merkurjev, Daria, Ohgi, Kenneth A., Meng, Da, Zhang, Jie, Evans, Christopher P., Rosenfeld, Michael G.

    Published in Nature (London) (29-08-2013)
    “…A study of prostate cancer cells reveals a transcriptional activation role for long non-coding RNAs (PRNCR1 and PCGEM1) that bind to the androgen receptor, and…”
    Get full text
    Journal Article
  4. 4

    Mechanisms of resistance in castration-resistant prostate cancer (CRPC) by Chandrasekar, Thenappan, Yang, Joy C, Gao, Allen C, Evans, Christopher P

    Published in Translational andrology and urology (01-06-2015)
    “…Despite advances in prostate cancer diagnosis and management, morbidity from prostate cancer remains high. Approximately 20% of men present with advanced or…”
    Get full text
    Journal Article
  5. 5

    Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer by Liu, Chengfei, Lou, Wei, Zhu, Yezi, Yang, Joy C, Nadiminty, Nagalakshmi, Gaikwad, Nilesh W, Evans, Christopher P, Gao, Allen C

    Published in Cancer research (Chicago, Ill.) (01-04-2015)
    “…The introduction of enzalutamide and abiraterone has led to improvement in the treatment of metastatic castration-resistant prostate cancer. However, acquired…”
    Get full text
    Journal Article
  6. 6

    Cross-sector comovements and policy impact in the COVID-19 stock market: A dynamic factor approach by Yang, Joy D. Xiuyao

    Published in Global finance journal (01-05-2023)
    “…This study investigates the remarkable comovements in U.S. equity returns during the COVID-19 pandemic. It constructs a dynamic factor model (DFM) to…”
    Get full text
    Journal Article
  7. 7

    A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine by Voss, Tiffini, Lipton, Richard B, Dodick, David W, Dupre, Nicole, Ge, Joy Yang, Bachman, Robert, Assaid, Christopher, Aurora, Sheena K, Michelson, David

    Published in Cephalalgia (01-08-2016)
    “…The aim of this trial was to evaluate the efficacy and tolerability of ubrogepant (MK-1602), a calcitonin gene-related peptide receptor antagonist (CGRP-RA),…”
    Get more information
    Journal Article
  8. 8

    Autophagy as a modulator and target in prostate cancer by Farrow, Jason M., Yang, Joy C., Evans, Christopher P.

    Published in Nature reviews. Urology (01-09-2014)
    “…Key Points Autophagy is a dynamic metabolic process that facilitates nutrient utilization and toxin removal: too little or too much autophagy can have…”
    Get full text
    Journal Article
  9. 9

    Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer by Zhao, Jinge, Ning, Shu, Lou, Wei, Yang, Joy C, Armstrong, Cameron M, Lombard, Alan P, D'Abronzo, Leandro S, Evans, Christopher P, Gao, Allen C, Liu, Chengfei

    Published in Molecular cancer therapeutics (01-08-2020)
    “…The next-generation antiandrogen drugs, XTANDI (enzalutamide), ZYTIGA (abiraterone acetate), ERLEADA (apalutamide) and NUBEQA (darolutamide) extend survival…”
    Get full text
    Journal Article
  10. 10
  11. 11

    AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer by Liu, Chengfei, Yang, Joy C, Armstrong, Cameron M, Lou, Wei, Liu, Liangren, Qiu, Xiaomin, Zou, Binhao, Lombard, Alan P, D'Abronzo, Leandro S, Evans, Christopher P, Gao, Allen C

    Published in Molecular cancer therapeutics (01-10-2019)
    “…The mechanisms resulting in resistance to next-generation antiandrogens in castration-resistant prostate cancer are incompletely understood. Numerous studies…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Distinct signaling mechanisms regulate migration in unconfined versus confined spaces by Hung, Wei-Chien, Chen, Shih-Hsun, Paul, Colin D, Stroka, Kimberly M, Lo, Ying-Chun, Yang, Joy T, Konstantopoulos, Konstantinos

    Published in The Journal of cell biology (02-09-2013)
    “…Using a microchannel assay, we demonstrate that cells adopt distinct signaling strategies to modulate cell migration in different physical microenvironments…”
    Get full text
    Journal Article
  14. 14

    Topographic diversity of fungal and bacterial communities in human skin by Findley, Keisha, Oh, Julia, Yang, Joy, Conlan, Sean, Deming, Clayton, Meyer, Jennifer A., Schoenfeld, Deborah, Nomicos, Effie, Park, Morgan, Kong, Heidi H., Segre, Julia A.

    Published in Nature (London) (20-06-2013)
    “…Microbial sequencing of samples obtained from multiple skin sites in healthy human adults shows that core-body and arm sites are dominated by fungal species of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis by Wang, Ling-Yu, Hung, Chiu-Lien, Chen, Yun-Ru, Yang, Joy C., Wang, Junjian, Campbell, Mel, Izumiya, Yoshihiro, Chen, Hong-Wu, Wang, Wen-Ching, Ann, David K., Kung, Hsing-Jien

    Published in Cell reports (Cambridge) (13-09-2016)
    “…The histone lysine demethylase KDM4A/JMJD2A has been implicated in prostate carcinogenesis through its role in transcriptional regulation. Here, we describe…”
    Get full text
    Journal Article
  17. 17

    Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine by Hewitt, David J, Aurora, Sheena K, Dodick, David W, Goadsby, Peter J, Ge, Yang Joy, Bachman, Robert, Taraborelli, Donna, Fan, Xiaoyin, Assaid, Christopher, Lines, Christopher, Ho, Tony W

    Published in Cephalalgia (01-04-2011)
    “…This study evaluated the CGRP receptor antagonist MK-3207 for acute treatment of migraine. Multicenter, double-blind, randomized, placebo-controlled,…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Confinement Sensing and Signal Optimization via Piezo1/PKA and Myosin II Pathways by Hung, Wei-Chien, Yang, Jessica R., Yankaskas, Christopher L., Wong, Bin Sheng, Wu, Pei-Hsun, Pardo-Pastor, Carlos, Serra, Selma A., Chiang, Meng-Jung, Gu, Zhizhan, Wirtz, Denis, Valverde, Miguel A., Yang, Joy T., Zhang, Jin, Konstantopoulos, Konstantinos

    Published in Cell reports (Cambridge) (17-05-2016)
    “…Cells adopt distinct signaling pathways to optimize cell locomotion in different physical microenvironments. However, the underlying mechanism that enables…”
    Get full text
    Journal Article
  20. 20

    Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer by Chen, Bo, Xu, Pengfei, Yang, Joy C., Nip, Christopher, Wang, Leyi, Shen, Yuqiu, Ning, Shu, Shang, Yufeng, Corey, Eva, Gao, Allen C., Gestwicki, Jason E., Wei, Qiang, Liu, Liangren, Liu, Chengfei

    Published in Oncogene (19-07-2024)
    “…Treatment-induced neuroendocrine prostate cancer (t-NEPC) often arises from adenocarcinoma via lineage plasticity in response to androgen receptor signaling…”
    Get full text
    Journal Article